NCT03182023

Brief Summary

Outcomes and Long-term Quality-of-life of Patients Treated With Extracorporeal Membrane Oxygenation are not known in china.A cross-section survey will be performed to assess the long-term outcome of these patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
83

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 7, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 9, 2017

Completed
1.6 years until next milestone

Study Start

First participant enrolled

January 30, 2019

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
Last Updated

July 19, 2022

Status Verified

July 1, 2022

Enrollment Period

4.9 years

First QC Date

June 7, 2017

Last Update Submit

July 17, 2022

Conditions

Long-term OutcomeExtracorporeal Membrane Oxygenation

Keywords

outcome,ECMO,Respiratory Failure,Circulatory Failure

Outcome Measures

Primary Outcomes (1)

  • Short Form-36 Health Status Questionnaire

    SF-36 is now widely utilized by managed care organizations and by Medicare for routine monitoring and assessment of care outcomes in adult patients.

    June,2017-May,2018

Secondary Outcomes (2)

  • EuroQol-5 Dimensions

    June,2017-May,2018

  • the St. George's Respiratory Questionnaire(SGRQ)

    June,2017-May,2018

Study Arms (1)

ECMO mode

ECMO mode includes Venovenous- ECMO and Venoarterial- ECMO

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients treated with ECMO from January 1，2015 to March 1,2017

You may qualify if:

  • patients treated with ECMO

You may not qualify if:

  • non-survivors of patients treated with ECMO，declined or lost to follow up

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nanjing Zhong-Da Hospital, Southeast University

Nanjing, Jiangsu, 210009, China

RECRUITING

MeSH Terms

Conditions

Shock

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Haibo Qiu

    professor

    STUDY DIRECTOR

Central Study Contacts

Ling Liu, MD

CONTACT

13851435472liulingdoctor@126.com

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

June 7, 2017

First Posted

June 9, 2017

Study Start

January 30, 2019

Primary Completion

December 30, 2023

Study Completion

December 30, 2023

Last Updated

July 19, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations

CN(1)